Graminex - Products containing Flower Pollen Extract - Flowers Aren't Just for Smelling Anymore

Products Containing Flower Pollen Extract:

Pollen Aid
Prostanex
Graminex Flower
Pollen Extract

We are GMP
Certified

Flowers aren’t just for smelling anymore - Proven treatment for enlarged prostate gains new ground

Men: You can treat your enlarged prostate now—without side effects. Sound too good to be true? Then, read on.

Benign prostatic hyperplasia (BPH), commonly known as enlarged prostate, is the silent disease among men. Afflicting over 10 million American males, BPH is a painful and embarrassing ailment. The disease begins with an increased need to urinate (often at night), frequently coupled with difficulty in doing so. This leads to general pain and discomfort in the groin region, a feeling of residual urine in the bladder even after voiding and, in serious cases, may result in the complete inability to urinate.

Why does this happen? Well, no one is exactly sure. The prostate itself is a walnut-sized gland that wraps around the urethra at the point of the bladder —its main function, helping produce semen. As a man ages, the prostate grows, eventually clamping down on the urethra and obstructing the flow of urine from the bladder.

Mainline treatments range from medications (with unpleasant and harmful side effects) to, in advanced cases, various forms of surgery—which can result in permanent impotence. This doesn’t have to be so.

The Cernilton solution

Used successfully for over 30 years in Europe and Asia, Cernilton (sir’-nill-tun) is a combination of extracts from the pollen of eight different plants: rye, maize, timothy, hazel, pine, oxeye daisy, sallow, and aspen. Discovered in Sweden almost half a century ago, this nonallergenic mixture has proven remarkably effective in the treatment of BPH.

In 1988, a double-blind, placebo-controlled study concluded that Cernilton improved nocturia (excessive urination at night—the principal symptom of BPH) in 68.8 percent of the cases, as opposed to 37.2 percent of the placebo group. In regard to residual urine (urine that remains in the bladder), 54.7 percent of the Cernilton group showed improvement, as compared with only 12.5 percent of the placebo.1

A second double-blind, placebo-controlled study, published in 1990, mirrored these results. In it, Cernilton was found to either eliminate or improve nocturia in 60 percent of the BPH patients tested. This compared with 30 percent of the subjects on the placebo. Even more impressive was the improvement in bladder emptying—57 percent of the Cernilton users vs. only 10 percent of the placebo group. All told, 69 percent of the Cernilton patients reported an overall improvement in their BPH symptoms, as compared with 29 percent in the placebo group.2

Some naked truth from the nude mouse

Because of the strong placebo effect found in most clinical trials of patients with BPH, researchers devised a study to eliminate that bias. Human BPH tissue was transplanted onto 12 nude mice. The mice were then separated into three groups: the first remaining a control, the second receiving a silicon implant to stimulate the BPH tissue, and the third receiving the implant and Cernilton. After six weeks, the tissue on the mice was examined, and the results were dramatic.

While the BPH tissue of the second group (which received the stimulation alone) grew, the tissue in the Cernilton group shrank—even with the stimulation. The researchers concluded that Cernilton is the first plant-derived drug to show a significant growth-inhibiting effect on human BPH tissue.3

What does this mean for those who suffer from BPH? Simply put, users of Cernilton can benefit from its proven ability to inhibit or reverse the growth of enlarged prostates.

"The Miracle of Cernitin"

In 1998, Cernilton ("Cernitin" is the European name) received strong support from a prominent Georgetown University doctor. In his book, The Prostate Cure: The Revolutionary, Natural Approach to Treating Enlarged Prostates, Harry Preuss, M.D., urged the use of Cernilton for BPH patients. Devoting an entire chapter (titled, "The Miracle of Cernitin") to the product, Preuss underscored the proven clinical effectiveness of the pollen extract, coupled with almost no side effects. Indeed, one study concluded that Cernilton’s tolerance was 99 percent among users (the single reported side effect being the rare upset stomach).4

According to Preuss, scientists have established three main beneficial components of Cernilton’s activity:

It acts as an anti-inflammatory, reducing swelling of the tissues of the prostate by inhibiting the formation of inflammatory chemicals.

It acts as a smooth-muscle relaxant in the bladder and prostate. As a result, urine flows through the urethra unobstructed.

It blocks the production of DHT (the male hormone that stimulates BPH), and thus inhibits prostate growth.

After evaluating scores of medical tests and studies demonstrating the effectiveness of Cernilton on BPH, Preuss concluded:

"Taken all together, studies conducted by Ake Asplund [one of the developers of Cernilton] and his staff, and by independent medical researchers around the world, show Cernitin, a standardized pollen extract, to be exceptionally effective in the treatment of BPH."5

Graminex, the producer of Cernilton, recommends taking 4 tablets a day. For maximum success, begin taking Cernilton in the early stages of BPH, as studies have shown it to be most effective in that period. Cernilton is available as indicated in your Source Directory below.

Urologe B, 28:301-306, 1988

British Journal of Urology, 66:398-404, 1990

"Experimental Treatment Studies with Cernilton N in Human Benign prostatic Hyperplasia"

"Possibilities and Limitations of Phytotherapy for Benign Prostatic Hyperplasia (BHP): Results of Treatment with Cernilton N for Stages 1-3 according to Alken (or II-IV according to Vahlensieck)"

Preuss, Harry G., M.D., Brenda Adderly, M.H.A. The Revolutionary, Natural Approach to Treating Enlarged Prostates (BPH), (Crown Publishers Inc., New York: 1998).

Article appeared in June 2000 Health Sciences Institute Members Alert

Health Sciences Institute
819 North Charles Street
Baltimore, MD 21201

For more info: (800) 981-7157